AngioDynamics has acquired Israel-based early commercial-stage medical device company Eximo Medical for $46m up-front consideration. The deal also includes $20m of contingent consideration based on the...
Olympus, a provider of optical and digital solutions for medical and surgical procedures, has introduced SnareMaster Plus hybrid hot/cold snare in the US. The SnareMaster Plus...
UK-based medical technology company LivaNova has enrolled the first patient in RECOVER clinical study to evaluate Vagus Nerve Stimulation (VNS) Therapy for Treatment-Resistant Depression (TRD). RECOVER...
Physicians Realty Trust (NYSE:DOC), (the “Company,” the “Trust,” “we,” “our” and “us”), a self-managed healthcare real estate investment trust, is providing this update related to its...
IRVINE, Calif.-Lindora, one of the largest medically supervised weight loss and wellness companies in the country, announced today that it has made a major strategic investment...
Sanofi has sent out a letter to medical professionals reassuring them that the French pharma giant was not leaving Bangladesh — a move that its 1,000...
Q BioMed Inc., a commercial stage biotech company, announced today it has entered into an exclusive distribution agreement for its non-opioid metastatic cancer pallion drug, Strontium-89...
Japan’s “overly restrictive” drug pricing policies risk diverting foreign direct investment to China and other markets, the chief executive of Bristol-Myers Squibb said on Thursday. The...
LOT Cargo has signed a Master Lease Agreement with temp controlled ULD producer CSafe Global for the use of its containers. “This is big step in...
ArisGlobal, the visionary provider of drug development technology for the life sciences industry, today announced the availability of LifeSphere® MultiVigilance 10 (LSMV10), the industry’s only end-to-end drug safety...
Biofourmis, a fast-growing global leader in digital therapeutics, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its machine-learning and artificial intelligence...
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, today announced that the first...
ExceleraRx Corp® announced today that members of the Excelera Network will have access to VYNDAQEL® (tafamidis meglumine) and VYNDAMAX™ (tafamidis), the first and only medications approved by...
SAN DIEGO-Viscient Biosciences (“Viscient”), a biotech therapeutics company working at the intersection of 3D tissue technology and transcriptomics technology to discover and develop drugs across a range...
PISCATAWAY, N.J.–IEEE, the world’s largest technical professional organization dedicated to advancing technology for humanity, and the IEEE Standards Association (IEEE SA) today announced the launch of an IEEE Industry...
Copyright © 2024 Medical Buyer